CrystalsFirst GmbH

scientific consulting

We also provide consulting services for in the target-to-hit phase and structurally-enabled campaigns. Our cutting-edge solutions, collaborative culture, speed and agility, to move with you in the direction that will best suit your quest for success.

Fragment-based drug design relies heavily on the availability of structural data for fragment expansion and evolution. Based on our track record in structural biology, we can support your campaigns by applying our proprietary know-how for de-risking. For example, our packing analyses and soakability assessments check for the compatibility of the crystals and ligands for co-structure determination.

Our spectrum of expertise also covers covalent and non-covalent strategies and library design for structurally-enabled screening and drug discovery campaigns. 

contact us to unlock chemical matter